Mohal Sarabhai, a serial entrepreneur and grandson of the illustrious scientist and industrialist Vikram Sarabhai, provides insights into the eye-catching group of companies he has been developing over the past 15 years, ranging from the effervescent products specialist Vovantis to the fermentation-focused API manufacturer Synbiotics. He also documents his two-fold partnership vision, which aims at bringing new technologies to India for the benefit of the larger population while partnering with international companies with no operations in India to establish the country as these companies’ manufacturing hub.
Your grandfather Vikram Sarabhai is widely regarded as the father of India's space program and as a key contributor to the development of nuclear power in the country, as well as the initiator of many significant social programs. As he was no stranger to the pharmaceutical sector either, could you provide insights into the key milestones that led Sarabhai Group to become India’s first and most prominent pharmaceutical group in the 1980s?
"We want to bring new technologies to India and be helpful to the larger population, following the path paved by my grandfather few decades ago"
